Readability of consumer medication information for intranasal corticosteroid inhalers

Steven E. Roskos, Lorraine S. Wallace, Barry D Weiss

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose. The readability of consumer medication information (CMI) inserts accompanying intranasal corticosteroid (INCS) inhalers currently prescribed in the United States was studied. Methods. INCS inhalers were identified (n = 7) using Epocrates RxPro and English-language CMI was obtained from each inhaler's manufacturer. The CMI was evaluated for reading grade level (using Fry's readability formula) and font size, dimensions (length and width), illustrations (diagrams and figures), and directions for use. Results. The mean ± S.D. reading grade level of the CMI was 6.9 ± 0.7 (range, 6-8). The mean ± S.D. font size was 9.0 + 2.2 (range, 6-12). The mean ± S.D. CMI page length and width were 31.3 ± 22.5 cm and 14.0 ± 12.9 cm, respectively. A device-overview figure was included in three of the seven educational samples. The mean size of illustrations was 7.9 cm2 (range, 2.9-25.9 cm2), with a mean ± S.D. of 7.6 ± 3.2 (range, 3-11) figures per CMI insert. Directions followed a logical, step-by-step chronological sequence in every CMI insert. Conclusion. Most CMI for INCS inhalers is written at a reading level slightly higher than recommended, printed in a font size smaller than recommended, and illustrated inadequately for successful patient education.

Original languageEnglish (US)
Pages (from-to)65-68
Number of pages4
JournalAmerican Journal of Health-System Pharmacy
Volume65
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Nebulizers and Vaporizers
Adrenal Cortex Hormones
Reading
Patient Education
Language
Equipment and Supplies
Direction compound

Keywords

  • Drug administration routes
  • Inhalers
  • Patient information
  • Readability
  • Steroids, cortico-

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Readability of consumer medication information for intranasal corticosteroid inhalers. / Roskos, Steven E.; Wallace, Lorraine S.; Weiss, Barry D.

In: American Journal of Health-System Pharmacy, Vol. 65, No. 1, 01.01.2008, p. 65-68.

Research output: Contribution to journalArticle

@article{659a7076fe2d4bc89c1f1a10816e280d,
title = "Readability of consumer medication information for intranasal corticosteroid inhalers",
abstract = "Purpose. The readability of consumer medication information (CMI) inserts accompanying intranasal corticosteroid (INCS) inhalers currently prescribed in the United States was studied. Methods. INCS inhalers were identified (n = 7) using Epocrates RxPro and English-language CMI was obtained from each inhaler's manufacturer. The CMI was evaluated for reading grade level (using Fry's readability formula) and font size, dimensions (length and width), illustrations (diagrams and figures), and directions for use. Results. The mean ± S.D. reading grade level of the CMI was 6.9 ± 0.7 (range, 6-8). The mean ± S.D. font size was 9.0 + 2.2 (range, 6-12). The mean ± S.D. CMI page length and width were 31.3 ± 22.5 cm and 14.0 ± 12.9 cm, respectively. A device-overview figure was included in three of the seven educational samples. The mean size of illustrations was 7.9 cm2 (range, 2.9-25.9 cm2), with a mean ± S.D. of 7.6 ± 3.2 (range, 3-11) figures per CMI insert. Directions followed a logical, step-by-step chronological sequence in every CMI insert. Conclusion. Most CMI for INCS inhalers is written at a reading level slightly higher than recommended, printed in a font size smaller than recommended, and illustrated inadequately for successful patient education.",
keywords = "Drug administration routes, Inhalers, Patient information, Readability, Steroids, cortico-",
author = "Roskos, {Steven E.} and Wallace, {Lorraine S.} and Weiss, {Barry D}",
year = "2008",
month = "1",
day = "1",
doi = "10.2146/ajhp070087",
language = "English (US)",
volume = "65",
pages = "65--68",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "1",

}

TY - JOUR

T1 - Readability of consumer medication information for intranasal corticosteroid inhalers

AU - Roskos, Steven E.

AU - Wallace, Lorraine S.

AU - Weiss, Barry D

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Purpose. The readability of consumer medication information (CMI) inserts accompanying intranasal corticosteroid (INCS) inhalers currently prescribed in the United States was studied. Methods. INCS inhalers were identified (n = 7) using Epocrates RxPro and English-language CMI was obtained from each inhaler's manufacturer. The CMI was evaluated for reading grade level (using Fry's readability formula) and font size, dimensions (length and width), illustrations (diagrams and figures), and directions for use. Results. The mean ± S.D. reading grade level of the CMI was 6.9 ± 0.7 (range, 6-8). The mean ± S.D. font size was 9.0 + 2.2 (range, 6-12). The mean ± S.D. CMI page length and width were 31.3 ± 22.5 cm and 14.0 ± 12.9 cm, respectively. A device-overview figure was included in three of the seven educational samples. The mean size of illustrations was 7.9 cm2 (range, 2.9-25.9 cm2), with a mean ± S.D. of 7.6 ± 3.2 (range, 3-11) figures per CMI insert. Directions followed a logical, step-by-step chronological sequence in every CMI insert. Conclusion. Most CMI for INCS inhalers is written at a reading level slightly higher than recommended, printed in a font size smaller than recommended, and illustrated inadequately for successful patient education.

AB - Purpose. The readability of consumer medication information (CMI) inserts accompanying intranasal corticosteroid (INCS) inhalers currently prescribed in the United States was studied. Methods. INCS inhalers were identified (n = 7) using Epocrates RxPro and English-language CMI was obtained from each inhaler's manufacturer. The CMI was evaluated for reading grade level (using Fry's readability formula) and font size, dimensions (length and width), illustrations (diagrams and figures), and directions for use. Results. The mean ± S.D. reading grade level of the CMI was 6.9 ± 0.7 (range, 6-8). The mean ± S.D. font size was 9.0 + 2.2 (range, 6-12). The mean ± S.D. CMI page length and width were 31.3 ± 22.5 cm and 14.0 ± 12.9 cm, respectively. A device-overview figure was included in three of the seven educational samples. The mean size of illustrations was 7.9 cm2 (range, 2.9-25.9 cm2), with a mean ± S.D. of 7.6 ± 3.2 (range, 3-11) figures per CMI insert. Directions followed a logical, step-by-step chronological sequence in every CMI insert. Conclusion. Most CMI for INCS inhalers is written at a reading level slightly higher than recommended, printed in a font size smaller than recommended, and illustrated inadequately for successful patient education.

KW - Drug administration routes

KW - Inhalers

KW - Patient information

KW - Readability

KW - Steroids, cortico-

UR - http://www.scopus.com/inward/record.url?scp=37849023498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849023498&partnerID=8YFLogxK

U2 - 10.2146/ajhp070087

DO - 10.2146/ajhp070087

M3 - Article

C2 - 18159042

AN - SCOPUS:37849023498

VL - 65

SP - 65

EP - 68

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 1

ER -